POP MMA

Sho Sekihara in critical condition after two brain surgeries following RIZIN 55 loss to Takumi Hamada

Published: . MMA.

RIZIN says flyweight Sho Sekihara, 33, suffered an acute subdural hematoma after his TKO loss to Takumi Hamada at RIZIN 55 and needed a second operation. His condition remains critical.

Headline graphic: Sho Sekihara in critical condition after RIZIN 55 bout with Takumi Hamada
Graphic: POP MMA

Japanese flyweight Sho Sekihara is in critical condition after undergoing two operations for an acute subdural hematoma suffered in his RIZIN 55 bout against Takumi Hamada, RIZIN announced on Thursday, November 12. The 33-year-old lost by TKO at 4:56 of the third round on November 8 at LaLa arena TOKYO-BAY in Chiba, Japan, and was carried from the ring on a stretcher.

What RIZIN said

In a statement on its official website, reported by Nikkan Sports, Sponichi and Chunichi Sports, RIZIN said Sekihara lost consciousness due to an acute subdural hematoma and had emergency surgery at the Chiba Emergency Medical Center near the venue. According to the statement, the surgery was completed and he survived, but his condition suddenly worsened the next morning and he needed a second operation. RIZIN said his condition remains serious and that it cannot yet be predicted how it will develop.

The promotion said it would share more details once his condition stabilises. It also asked fans not to be swayed by unfounded information and not to spread claims that differ from the facts.

Father's message

RIZIN also published a comment from Sekihara's father, Masamichi. He thanked fans for their support and said his son "is still fighting" after the bout. He said he keeps telling him, "You're a man who never gives up, aren't you?" He asked fans to pray that his son regains consciousness as soon as possible. (The quotes are translated from Japanese.)

The fight

Sekihara (RESURGO MMA) vs Hamada (THE BLACKBELT JAPAN) was the second bout of the night, a three-round RIZIN flyweight contest at 57 kg. Hamada, the reigning King of Pancrase flyweight champion, was making his RIZIN debut. According to Gong Kakutogi, Sekihara took Hamada down early. Hamada had the better of the striking from the middle of the fight onward. In the final round Hamada lifted Sekihara and slammed him to the mat, and Sekihara hit the back of his head. Hamada followed with punches, and the referee stopped the fight with four seconds left.

At the post-event press conference, RIZIN CEO Nobuyuki Sakakibara said Sekihara had been taken to an emergency hospital for treatment. ENCOUNT reported that he said Sekihara's life was not in danger at that point and that RIZIN would give an update once it understood the injury.

Previous brain injury

This is not Sekihara's first acute subdural hematoma. Nikkan Sports reports that he developed one after a decision loss to Yuki Ito at DEEP 107 IMPACT at Korakuen Hall on May 8, 2022. He came back after 726 days at DEEP 119 IMPACT on May 3, 2024, beating Masato Nakamura by decision. Gong Kakutogi notes that during his time away he competed in jiu-jitsu and added more grappling to his game. RIZIN 55 was his first RIZIN appearance since November 2021.

MMA Mania raised the question of whether Sekihara should have been cleared to fight again after his first brain bleed. RIZIN has not addressed this publicly.

POP MMA will update this story when RIZIN releases more information.

Source: Nikkan Sports: Sekihara undergoes second surgery for acute subdural hematoma, condition remains serious (Nov 12, 2026), Sponichi Annex: Sekihara has two surgeries for acute subdural hematoma, RIZIN statement in full (Nov 12, 2026), Chunichi Sports: Sekihara's condition worsened, re-operation; father Masamichi's comment released (Nov 12, 2026), MMA Mania: RIZIN 55's Sho Sekihara fighting for life in hospital after brutal slam knockout (Nov 12, 2026), Gong Kakutogi: Hamada beats Sekihara by TKO after epic battle; Sekihara taken to hospital on stretcher (Nov 8, 2026), ENCOUNT: Sakakibara explains Sekihara's condition at RIZIN 55 post-event press conference (Nov 8, 2026).